Retinoblastoma
Genetics — RB1 Gene and Knudson's Two-Hit Hypothesis
| Type | Proportion | Mechanism | Presentation |
|---|---|---|---|
| Hereditary | ~40% | First hit inherited (present in every cell) + one somatic second hit needed | Earlier presentation; frequently bilateral/multifocal |
| Sporadic | ~60% | Both hits must occur somatically in the same single retinal cell (statistically much less likely) | Later presentation; near-exclusively unilateral, unifocal |
[Diagram: Knudson two-hit hypothesis diagram: hereditary (germline first hit + single somatic second hit) vs sporadic (both hits somatic in one cell)]
Clinical Presentation — Leukocoria and its Differential Diagnosis
Leukocoria (abnormal white pupillary reflex) is the most common presenting sign. Differential diagnosis:
- Congenital cataract
- Persistent Fetal Vasculature (formerly PHPV)
- Coats disease
- Retinopathy of prematurity (Section 1, Q8)
- Ocular toxocariasis
International Classification of Intraocular Retinoblastoma (ICIR/IIRC)
Groups A–E (increasing severity) — guides eye-preserving vs enucleation decision; Group E generally requires enucleation.
Eye-Preserving Therapies
| Therapy | Description |
|---|---|
| Systemic chemotherapy (“chemoreduction”) | Shrinks tumor to allow subsequent limited, eye-preserving local control |
| Intra-arterial chemotherapy | Direct ophthalmic artery catheterization — high local concentration, minimized systemic exposure; relatively recent advance |
| Laser photocoagulation/cryotherapy | For smaller, peripheral/accessible tumors |
| Plaque brachytherapy | Localized radioactive plaque over the tumor |